外体非编码RNA:一种新的黑色素瘤诊断方法和治疗策略
Jie Liu1, Xiaoping Hu1, Wenqiang Xin2,3
1Department of Dermatology, Skin Research Institute of Peking University Shenzhen Hospital, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong Province, China.
Current medicinal chemistry
|October 25, 2023
概括
外基因组携带影响癌症进展的非编码RNA (ncRNA). 本综述探讨了恶性黑色素瘤 (MM) 中的外体ncRNAs 对于潜在的诊断和治疗应用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 恶性黑色素瘤 (MM) 是一种具有高死亡率的侵袭性癌症.
- 目前的治疗方法面临着诸如瘤复发和耐药性等挑战.
- 外体细胞介导细胞间通信,携带生物活性分子,如非编码RNA (ncRNA).
研究的目的:
- 审查当前对黑色素瘤诊断和治疗的理解.
- 探索外体ncRNAs在恶性黑色素瘤中的作用.
- 识别潜在的诊断生物标志物和治疗点.
主要方法:
- 对黑色素瘤,外体和ncRNA研究的文献综述.
- 对外体ncRNAs在黑色素瘤进展中的参与进行分析.
- 对MM中的外体ncRNAs当前知识的综合.
主要成果:
- 外体ncRNAs涉及到关键的癌症过程,包括扩散,血管生成,免疫调节,入侵,转移和治疗耐药性.
- 在MM中外体ncRNAs的特定功能作用仍在研究中.
- 外体ncRNAs显示出作为黑色素瘤诊断的生物标志物和治疗点的希望.
结论:
- 外体的ncRNA在恶性黑色素瘤中起着重要作用.
- 对外体ncRNA的进一步研究可能会导致黑色素瘤的新型诊断和治疗策略.
- 了解外体ncRNA机制可能为黑色素瘤进展提供新的见解.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K


